Xadago for Parkinson disease (adjunct to levodopa)
Quick answer: Xadago is used for Parkinson disease (adjunct to levodopa) as part of a mao-b inhibitor treatment regimen. Selective, reversible monoamine oxidase B inhibitor that also blocks sodium channels and modulates glutamate release The specific dosing for Parkinson disease (adjunct to levodopa) is determined by your prescriber based on individual factors.
Why is Xadago used for Parkinson disease (adjunct to levodopa)?
Xadago belongs to the MAO-B inhibitor class. Selective, reversible monoamine oxidase B inhibitor that also blocks sodium channels and modulates glutamate release This action makes it useful for treating or managing Parkinson disease (adjunct to levodopa) in patients for whom this approach is clinically appropriate.
It is one of several treatment options. Whether Xadago is the right choice for a specific patient depends on the type and severity of Parkinson disease (adjunct to levodopa), response to previous treatments, individual risk factors, and clinical guidelines.
Typical dosing for Parkinson disease (adjunct to levodopa)
Common adult dosing range: 50-100 mg once daily. The actual dose for Parkinson disease (adjunct to levodopa) depends on:
- Severity of the condition
- Patient's age, weight, and organ function
- Other medications being taken
- Treatment response and tolerability
For complete dosing details, see the Xadago medicine page.
What to expect
Xadago treatment for Parkinson disease (adjunct to levodopa) typically involves:
- Onset of effect: varies by indication and dose — some effects are immediate, others take days to weeks
- Treatment duration: some courses are short-term, others are long-term or lifelong depending on Parkinson disease (adjunct to levodopa)
- Monitoring: follow-up visits to assess response and adjust dosing
- Side-effect awareness: learning what to expect and what warrants medical attention
Alternatives to consider
If Xadago is not appropriate or not tolerated, alternatives within the same class or different therapeutic classes may be considered. See all MAO-B inhibitor for related options.
When to talk to your doctor
Discuss with your prescriber if you experience:
- Inadequate symptom control on Xadago
- Side effects affecting daily life
- New medications or supplements that may interact
- Pregnancy planning or pregnancy
- Major changes in health status
Related information
Xadago full prescribing information · All MAO-B inhibitor alternatives
Frequently asked questions
How effective is Xadago for Parkinson disease (adjunct to levodopa)?
Effectiveness varies by individual response, dose, and severity. Xadago is one of several treatment options for Parkinson disease (adjunct to levodopa), supported by clinical evidence within the mao-b inhibitor class. Discuss expected response with your prescriber.
How long do I need to take Xadago for Parkinson disease (adjunct to levodopa)?
Treatment duration depends on the nature of Parkinson disease (adjunct to levodopa) — some treatments are short-term, others long-term or lifelong. Never stop on your own; discontinuation requires clinical guidance to avoid relapse or rebound effects.
What are the main side effects of Xadago when used for Parkinson disease (adjunct to levodopa)?
Common and serious side effects are class-related and substance-specific. See the full medicine page for the complete profile. Report any unexpected effects to your prescriber.
Are there alternatives to Xadago for Parkinson disease (adjunct to levodopa)?
Yes. Multiple medicines and non-drug options exist for Parkinson disease (adjunct to levodopa). Alternatives within the mao-b inhibitor class share mechanisms; other classes may offer different approaches. Discuss with your clinician.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.